Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

12.3%

9 terminated/withdrawn out of 73 trials

Success Rate

86.2%

-0.4% vs industry average

Late-Stage Pipeline

25%

18 trials in Phase 3/4

Results Transparency

11%

6 of 56 completed trials have results

Key Signals

6 recruiting6 with results6 terminated

Enrollment Performance

Analytics

N/A

29(60.4%)

Phase 4

16(33.3%)

Phase 3

2(4.2%)

Phase 2

1(2.1%)

48Total

N/A(29)

Phase 4(16)

Phase 3(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (73)

Showing 20 of 73 trials

NCT07615504Recruiting

Better Tests- Improving Diagnostic Accuracy and Prognostication in Interstitial Lung Diseases

Role: collaborator

NCT07522528Not ApplicableRecruiting

Biologics and Paediatric Enteral Nutrition in Crohn's Disease Study

Role: collaborator

NCT06714630Recruiting

The PROSECCA Study, Answering New Questions in Prostate Cancer

Role: collaborator

NCT04577716Completed

Predicting Endoleaks Following Endovascular Aortic Aneurysm Repair Using 18F-Sodium Fluoride

Role: collaborator

NCT06972017Not Yet Recruiting

Peri-Operative Surgical Care Optimisation for Patients Requiring Emergency Surgery

Role: collaborator

NCT06169163Recruiting

Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasms

Role: collaborator

NCT03299569Recruiting

Establishing the Incidence of Tako-tsubo Cardiomyopathy in Scotland

Role: collaborator

NCT05412758Not ApplicableRecruiting

Augmented Response of Volatile Biomarkers in Assessment of Oesophagogastric Cancer (AROMA 1 / BIORESOURCE)

Role: collaborator

NCT04290273Not ApplicableWithdrawn

Characterisation of the Time-course Response of UV-induced Erythema

Role: collaborator

NCT05164549Phase 3Completed

Extended-release Pharmacotherapy for Opioid Use Disorder

Role: collaborator

NCT05408169Not ApplicableCompleted

Increasing Uptake of Bowel Screening

Role: collaborator

NCT04817332Phase 3Completed

STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19

Role: collaborator

NCT04159545Completed

Future Destinations: Journeys Towards Citizenship

Role: collaborator

NCT03489746Not ApplicableWithdrawn

Steroid Withdrawal Intervention in Fife and Tayside

Role: lead

NCT05057260Unknown

LOng COvid Multidisciplinary Consortium: Optimising Treatments and servIces Across the NHS (LOCOMOTION)

Role: collaborator

NCT03747107Completed

Pharmacist and Data Driven Quality Improvement in Primary Care

Role: collaborator

NCT02701348Not ApplicableCompleted

Radiological and Biological Tumoural and Peri-tumoural Factors in Neoadjuvant Endocrine-treated Breast Cancers

Role: lead

NCT02468271Completed

Clinimetric Properties of Outcome Measures in Bronchiectasis in the UK

Role: collaborator

NCT02745496Not ApplicableCompleted

Advanced Magnetic Resonance Imaging (MRI) in Men With Suspected Prostate Cancer

Role: collaborator

NCT02653209Phase 4Completed

TriMaster: Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione as Third Line Therapy in Patients With Type 2 Diabetes.

Role: collaborator